Xiao‐Ming Meng

19.1k total citations · 3 hit papers
256 papers, 15.3k citations indexed

About

Xiao‐Ming Meng is a scholar working on Molecular Biology, Nephrology and Epidemiology. According to data from OpenAlex, Xiao‐Ming Meng has authored 256 papers receiving a total of 15.3k indexed citations (citations by other indexed papers that have themselves been cited), including 157 papers in Molecular Biology, 53 papers in Nephrology and 49 papers in Epidemiology. Recurrent topics in Xiao‐Ming Meng's work include Liver Disease Diagnosis and Treatment (42 papers), Liver physiology and pathology (37 papers) and Chronic Kidney Disease and Diabetes (31 papers). Xiao‐Ming Meng is often cited by papers focused on Liver Disease Diagnosis and Treatment (42 papers), Liver physiology and pathology (37 papers) and Chronic Kidney Disease and Diabetes (31 papers). Xiao‐Ming Meng collaborates with scholars based in China, Hong Kong and United States. Xiao‐Ming Meng's co-authors include Hui Y. Lan, David J. Nikolic‐Paterson, Arthur C.K. Chung, Jun Li, Jun Li, Xiao Ru Huang, Taotao Ma, Cheng Huang, Haiyong Chen and Patrick Ming‐Kuen Tang and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xiao‐Ming Meng

253 papers receiving 15.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TGF-β: the master regulator of fibrosis

2016 2.7k citations Xiao‐Ming Meng, David J. Nikolic‐Paterson et al. Nature Reviews Nephrology profile →
TGF-Î²/Smad signaling in renal fibrosis

2015 572 citations Xiao‐Ming Meng, Jun Li et al. profile →
Inflammatory processes in renal fibrosis

2014 571 citations Xiao‐Ming Meng, David J. Nikolic‐Paterson et al. Nature Reviews Nephrology profile →

Peers

Countries citing papers authored by Xiao‐Ming Meng

Since Specialization

Citations

This map shows the geographic impact of Xiao‐Ming Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiao‐Ming Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiao‐Ming Meng more than expected).

Fields of papers citing papers by Xiao‐Ming Meng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiao‐Ming Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiao‐Ming Meng. The network helps show where Xiao‐Ming Meng may publish in the future.

Co-authorship network of co-authors of Xiao‐Ming Meng

This figure shows the co-authorship network connecting the top 25 collaborators of Xiao‐Ming Meng. A scholar is included among the top collaborators of Xiao‐Ming Meng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiao‐Ming Meng. Xiao‐Ming Meng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Kidney-targeting DNA tetrahedral molecular cage synergistically inhibits acute kidney injury by clearing ROS and activating HO-1 2025 ·Biomaterials ·Yu Ren, Yuhang Dong, (unknown), Keying Xu, (unknown), (unknown), (unknown), Changlu Xu, Min Yang, Min Woo Lee, Xiao‐Ming Meng, Jie Wang	2
2	METTL1-mediated m ⁷ G methylation of Sarm1 mRNA promotes macrophage inflammatory responses and multiple organ injury 2025 ·Science Immunology ·Chao Hou, Xinru Zhang, Jie Wei, Jianan Wang, Jian Gao, (unknown), (unknown), (unknown), Tao Sun, (unknown), Ju-tao Yu, Xiao-Guo Suo, Zi Mei, Fanrong Zhang, Juan Jin, (unknown), Yuxian Shen, Xiao‐Ming Meng	1
3	Innate immune cells in acute and chronic kidney disease 2025 ·Nature Reviews Nephrology ·Xiao‐Ming Meng, Li Wang, David J. Nikolic‐Paterson, Hui Y. Lan	11
4	Insulin-like growth factor-binding protein 7 exacerbates inflammatory response and lipid metabolism imbalance in alcohol-associated liver disease 2024 ·Free Radical Biology and Medicine ·(unknown), Ruonan Wang, Le Chen, (unknown), Wei Qiu, (unknown), (unknown), Min Li, X. Ma, Xiao‐Ming Meng, (unknown)	2
5	N6-Methyladenosine modification of circDcbld2 in Kupffer cells promotes hepatic fibrosis via targeting miR-144-3p/Et-1 axis 2024 ·Acta Pharmaceutica Sinica B ·Sai Zhu, Xin Chen, (unknown), Xiaofeng Li, Yu Chen, Liang‐yun Li, Xiao-Guo Suo, Chuanhui Xu, (unknown), Jianan Wang, Hua Wang, Lei Zhang, Xiao‐Ming Meng, Cheng Huang, (unknown)	4
6	Time-programmed activation of CD47 disruption and immunogenic cell death with Cas9 ribonucleoprotein nanocapsule for improved cancer immunotherapy 2023 ·Chemical Engineering Journal ·(unknown), (unknown), Chun Wang, Ziyao Kang, Zheng Pan, Jihui Tang, (unknown), Xiao Wang, Xiao‐Ming Meng, Zhifei Cheng, Yang Liu, Qi Liu	7
7	Novel insights into STAT3 in renal diseases 2023 ·Biomedicine & Pharmacotherapy ·Ju-tao Yu, (unknown), Xiangyü Li, Rui Hou, Xiaowei Hu, Jianan Wang, (unknown), (unknown), Manman Xie, Yuhang Dong, Xiaoyu Shen, Juan Jin, Jiagen Wen, Mingming Liu, Wei Wang, Xiao‐Ming Meng	12
8	GRP/GRPR enhances alcohol-associated liver injury through the IRF1-mediated Caspase-1 inflammasome and NOX2-dependent ROS pathway 2023 ·Hepatology ·Hai-Di Li, Xin Chen, Jiejie Xu, Lin Zhu, Chao Li, Xiaolong Sun, Xiaofeng Li, (unknown), Juanjuan Li, Sheng Wang, Yong He, Hua Wang, Cheng Huang, Xiao‐Ming Meng, Jun Li	21
9	GRP/GRPR signaling pathway aggravates hyperuricemia-induced renal inflammation and fibrosis via ABCG2-dependent mechanisms 2023 ·Biochemical Pharmacology ·(unknown), (unknown), Xuemei Liu, Heng Zhang, Ying Jie, (unknown), (unknown), (unknown), (unknown), (unknown), Xiao‐Ming Meng, Juan Jin	10
10	Dissecting the immune discrepancies in mouse liver allograft tolerance and heart/kidney allograft rejection 2023 ·Cell Proliferation ·(unknown), Fang Ye, Hui Li, Chengxuan Yu, (unknown), Yanyu Xiao, Haide Chen, Junqing Wu, Jiaqi Li, Lijiang Fei, Yijun Wu, Xiao‐Ming Meng, Guoji Guo, (unknown)	5
11	Protective effect of inhibiting necroptosis on gentamicin‐induced nephrotoxicity 2022 ·The FASEB Journal ·(unknown), Qian Gong, (unknown), (unknown), (unknown), Fang Wang, Xiaowen Feng, (unknown), Chao Li, (unknown), Xuefu Wang, Xiao‐Ming Meng, Jun Li, Jiagen Wen	7
12	METTL3-mediated m6A modification of TIMP2 mRNA promotes podocyte injury in diabetic nephropathy 2022 ·Molecular Therapy ·Ling Jiang, Xue‐qi Liu, (unknown), Li Gao, Han-xu Zeng, Xian Wang, Yuebo Huang, Wei Zhu, Jianan Wang, Jiagen Wen, Xiao‐Ming Meng, Yonggui Wu	135
13	Arrb2 causes hepatic lipid metabolism disorder via AMPK pathway based on metabolomics in alcoholic fatty liver 2021 ·Clinical Science ·Ying-Yin Sun, (unknown), (unknown), Lei Yang, Xin Chen, Hai-Di Li, Xiaofeng Li, Cheng Huang, Xiao‐Ming Meng, Hua Wang, Jun Li	12
14	MicroRNA‐708 modulates Hepatic Stellate Cells activation and enhances extracellular matrix accumulation via direct targeting TMEM88 2020 ·Journal of Cellular and Molecular Medicine ·Tao Xu, (unknown), Liang‐yun Li, Shuang Hu, Hong Zhou, Chenchen Yang, Junfa Yang, Haodong Li, Yuming Liu, Xiao‐Ming Meng, Jun Li	16
15	DNA methylation of FTO promotes renal inflammation by enhancing m6A of PPAR-α in alcohol-induced kidney injury 2020 ·Pharmacological Research ·Ju-tao Yu, Xiaowei Hu, Haiyong Chen, Qin Yang, Hai-Di Li, Yuhang Dong, Yao Zhang, Jianan Wang, Juan Jin, Yonggui Wu, Jun Li, Jin‐Fang Ge, Xiao‐Ming Meng	64
16	Potential therapeutic targets and promising drugs for combating SARS‐CoV‐2 2020 ·British Journal of Pharmacology ·Hong Zhou, Fang Yan, Tao Xu, Wei‐Jian Ni, Aizong Shen, Xiao‐Ming Meng	63
17	PLK1 regulates hepatic stellate cell activation and liver fibrosis through Wnt/β‐catenin signalling pathway 2020 ·Journal of Cellular and Molecular Medicine ·Yu Chen, Xin Chen, (unknown), Sai Zhu, Fangtian Bu, (unknown), Xiao‐Ming Meng, Cheng Huang, (unknown)	33
18	Alcohol promotes renal fibrosis by activating Nox2/4-mediated DNA methylation of Smad7 2020 ·Clinical Science ·Qin Yang, Haiyong Chen, Jianan Wang, (unknown), Ling Jiang, Weifeng Wu, Biao Wei, Li Gao, Qiuying Ma, Xue‐qi Liu, (unknown), Jiagen Wen, Juan Jin, Yan Huang, Wei‐Jian Ni, Taotao Ma, Jun Li, Xiao‐Ming Meng	26
19	RIPK1 inhibitor Cpd-71 attenuates renal dysfunction in cisplatin-treated mice via attenuating necroptosis, inflammation and oxidative stress 2019 ·Clinical Science ·Jianan Wang, Mingming Liu, Fang Wang, Biao Wei, Qin Yang, Yuting Cai, Xin Chen, Xue‐qi Liu, Ling Jiang, Chao Li, Xiaowei Hu, Ju-tao Yu, Taotao Ma, Juan Jin, Yonggui Wu, Jun Li, Xiao‐Ming Meng	67
20	Estrogen Stimulates the Expression of Mismatch Repair Gene hMLH1 in Colonic Epithelial Cells 2010 ·Cancer Prevention Research ·Peng Jin, Xiaojuan Lu, Jianqiu Sheng, Lei Fu, Xiao‐Ming Meng, Xin Wang, Taiping Shi, Shirong Li, Jianyu Rao	24

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact